Metastatic Nonsmall Cell Lung Cancer
Oncology·MeSH: Lung Neoplasms
Prevalence
6.0 / 100K
Incidence
8.0 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
Frequently asked questions
How many drugs are in development for Metastatic Nonsmall Cell Lung Cancer?
BioSniper tracks 1 drug in development for Metastatic Nonsmall Cell Lung Cancer across 1 company.
How many clinical trials target Metastatic Nonsmall Cell Lung Cancer?
There are 3 clinical trials targeting Metastatic Nonsmall Cell Lung Cancer tracked by BioSniper.
What is the prevalence of Metastatic Nonsmall Cell Lung Cancer?
The estimated prevalence of Metastatic Nonsmall Cell Lung Cancer is approximately 6.0 per 100,000 population.
Deep-dive into Metastatic Nonsmall Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis